BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22940586)

  • 1. Influence of sildenafil on the antidepressant activity of bupropion and venlafaxine in the forced swim test in mice.
    Socała K; Nieoczym D; Wyska E; Poleszak E; Wlaź P
    Pharmacol Biochem Behav; 2012 Dec; 103(2):273-8. PubMed ID: 22940586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the activity of two atypical antidepressant drugs, mianserin and tianeptine, in the forced swim test in mice.
    Socała K; Nieoczym D; Wyska E; Poleszak E; Wlaź P
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):121-6. PubMed ID: 22406168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil, a phosphodiesterase type 5 inhibitor, reduces antidepressant-like activity of paroxetine in the forced swim test in mice.
    Socała K; Nieoczym D; Wyska E; Poleszak E; Wlaź P
    Pharmacol Rep; 2012; 64(5):1259-66. PubMed ID: 23238482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the antidepressant activity of amitriptyline but not desipramine, in the forced swim test in mice.
    Socała K; Nieoczym D; Wyska E; Poleszak E; Wlaź P
    J Neural Transm (Vienna); 2012 Jun; 119(6):645-52. PubMed ID: 22215207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the phosphodiesterase type 5 inhibitor, sildenafil, on antidepressant-like activity of magnesium in the forced swim test in mice.
    Socała K; Nieoczym D; Poleszak E; Wlaź P
    Pharmacol Rep; 2012; 64(1):205-11. PubMed ID: 22580537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2007 Aug; 569(1-2):77-83. PubMed ID: 17585901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of caffeine on the activity of moclobemide, venlafaxine, bupropion and milnacipran in the forced swim test in mice.
    Poleszak E; Szopa A; Wyska E; Wośko S; Serefko A; Wlaź A; Pieróg M; Wróbel A; Wlaź P
    Life Sci; 2015 Sep; 136():13-8. PubMed ID: 26135623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the role of protein kinase-G in the antidepressant-like response of sildenafil in combination with muscarinic acetylcholine receptor antagonism.
    Liebenberg N; Wegener G; Harvey BH; Brink CB
    Behav Brain Res; 2010 May; 209(1):137-41. PubMed ID: 20117144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
    Dhir A; Malik S; Kessar SV; Singh KN; Kulkarni SK
    Eur Neuropsychopharmacol; 2011 Sep; 21(9):705-14. PubMed ID: 21277753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant-like properties of phosphodiesterase type 5 inhibitors and cholinergic dependency in a genetic rat model of depression.
    Liebenberg N; Harvey BH; Brand L; Brink CB
    Behav Pharmacol; 2010 Sep; 21(5-6):540-7. PubMed ID: 20555254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice.
    Dhir A; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):921-5. PubMed ID: 17379375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
    Dhir A; Kulkarni SK
    Eur J Pharmacol; 2007 Jul; 568(1-3):177-85. PubMed ID: 17509558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of nitric oxide (NO) signalling pathway in the antidepressant activity of essential oil of Valeriana wallichii Patchouli alcohol chemotype.
    Sah SP; Mathela CS; Chopra K
    Phytomedicine; 2011 Nov; 18(14):1269-75. PubMed ID: 21795033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sildenafil on the activity of some antidepressant drugs and electroconvulsive shock treatment in the forced swim test in mice.
    Socała K; Nieoczym D; Wyska E; Wlaź P
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):339-349. PubMed ID: 28013355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant-like effect of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a putative trace amine receptor ligand involves l-arginine-nitric oxide-cyclic guanosine monophosphate pathway.
    Dhir A; Kulkarni SK
    Neurosci Lett; 2011 Oct; 503(2):120-4. PubMed ID: 21875647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis.
    Krass M; Wegener G; Vasar E; Volke V
    Behav Brain Res; 2011 Mar; 218(1):57-63. PubMed ID: 21093491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxine.
    Dhir A; Kulkarni SK
    Neurosci Lett; 2007 Jun; 420(3):204-8. PubMed ID: 17532136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo.
    Cooper BR; Hester TJ; Maxwell RA
    J Pharmacol Exp Ther; 1980 Oct; 215(1):127-34. PubMed ID: 6778989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antidepressant-like activity by joint administration of imipramine and magnesium in the forced swim test: Behavioral and pharmacokinetic studies in mice.
    Poleszak E; Wlaź P; Szewczyk B; Kedzierska E; Wyska E; Librowski T; Szymura-Oleksiak J; Fidecka S; Pilc A; Nowak G
    Pharmacol Biochem Behav; 2005 Jul; 81(3):524-9. PubMed ID: 15936065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.